Please login to the form below

Not currently logged in
Email:
Password:

board of directors

This page shows the latest board of directors news and features for those working in and with pharma, biotech and healthcare.

Boehringer spends €1.18bn to acquire NBE-Therapeutics

Boehringer spends €1.18bn to acquire NBE-Therapeutics

The acquisition is expected to close, subject to customary closing conditions, during the first quarter of 2021. ... board of managing directors.

Latest news

  • Purdue Pharma files for bankruptcy after opioid settlement Purdue Pharma files for bankruptcy after opioid settlement

    Other contributions include the formation of a new company called NewCo, which will be governed by a new board selected by the claimants and approved by the bankruptcy court. ... to cope with the opioid crisis,” said Steve Miller, chairman of

  • Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows Ex-FDA chief Gottlieb's quick move to pharma raises eyebrows

    Will join Pfizer board. Just 83 days after leaving his Commissioner role at the FDA, Scott Gottlieb has joined the board of big pharma group Pfizer. ... We are fortunate to have D. Gottlieb join Pfizer’s Board of Directors,” said Pfizer executive

  • Amgen buys Danish partner Nuevolution for $167m Amgen buys Danish partner Nuevolution for $167m

    The board of Copenhagen-based, Sweden-listed Nuevolution has accepted a 32.5 Swedish krona per share offer from Amgen, which is a 169% premium on the company’s closing price ... The biotech’s board of directors has unanimously recommended the deal to

  • Blood disorder specialists Imara raises $63m Blood disorder specialists Imara raises $63m

    mechanism of targeting both red and white blood cells make the drug highly potent. ... In return, Arix owns 10% of the company and Investment Director Mark Chin will join Imara’s board of directors.

  • Novartis and Syncona back new Swiss biotech Anaveon Novartis and Syncona back new Swiss biotech Anaveon

    Andreas Katopodis. The company has also added a few new faces to its board of directors, including Florian Muellershausen from Novartis Venture Fund, which backed the series A financing round. ... Syncona is the venture funding group driving a lot of

More from news
Approximately 0 fully matching, plus 158 partially matching documents found.

Latest Intelligence

  • Charting a course for expansion Charting a course for expansion

    a key licensing agreement and the not inconsequential matter of a management reshuffle. ... In February deputy CEO Christel Bories was ousted, with the company highlighting disagreements over strategy between her and its board of directors.

  • Dispensing with the past Dispensing with the past

    The vast majority of board directors, nearly two-thirds (63%), have previous general management experience, and nearly half (48%) have previous or current CEO experience of a commercial, for-profit company. ... Current board composition at the top pharma

  • Tracking comms trends: 2 + 2 = 7: bad maths, or good sense? Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

    And it's true for people too. Whether it's a premier league football team or a FTSE 500 board of directors, what makes these high performing teams so successful is ... For both of these trends we are seeing pharma look outside its own walls – fresh,

  • Healthcare and the digital revolution Healthcare and the digital revolution

    Experience suggests that the key to securing a competitive advantage is to embrace digital as a solution from within the business, with effective governance at the board level and good internal ... Digital leadership from the board of directors sends out

  • The human perspective The human perspective

    Overseeing these strategic manoeuvres will be Hubertus von Baumbach, who takes over as chairman of the board of managing directors from Prof Andreas Barner on 1 July. ... Neumann was appointed to his present role, where he has responsibility for the

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Ex-J&J exec Denice Torres joins bluebird bio’s board Ex-J&J exec Denice Torres joins bluebird bio’s board

    Ex-Johnson &Johnson executive Denice Torres (pictured above) has been appointed to bluebird bio’s board of directors. ... We’re excited to welcome Denice to the Board to help guide bluebird as we reach the next stage in our evolution,” said Nick

  • Ex-Roche CMO Sandra Horning joins Gilead’s board of directors Ex-Roche CMO Sandra Horning joins Gilead’s board of directors

    Horning has also recently joined the board of directors at Moderna, a clinical-stage biotechnology company based in Cambridge, Massachusetts. ... We are very pleased to welcome Sandra Horning to our Board of Directors,” said Daniel O’Day (pictured

  • New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

    He initially joined Merus’ board of directors back in June 2019, bringing more than 15 years of experience managing and leading biotechnology research and development. ... Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney

  • New hires at Abbott, Kite and Arrakis Therapeutics New hires at Abbott, Kite and Arrakis Therapeutics

    We're confident he will continue Abbott's outstanding legacy of success," said William Osborn, lead director and chair of the Nominations and Governance Committee of Abbott’s Board of Directors. ... chairman of its Board of Directors. She has nearly 30

  • Industry appointments Industry appointments

    Meanwhile, as part of a board refreshment process, Allergan has also announced that Neurobiologist Michael Greenberg will join its board of directors. ... Following the retirement of Fred Weiss and the addition of Greenberg, Allergan's Board of Directors

More from appointments
Approximately 0 fully matching, plus 218 partially matching documents found.

Latest from PMHub

  • Empowering Medtech Innovation

    In this exciting episode of Impetus Digital‘s Fireside Chat series, I sat down with Scott Phillips, President at StarFish Medical, to learn more about his ongoing work to empower MedTech ... Chair of the Board of Directors at LifeSciences BC.

  • Laura Brown appointed to Ashfield Meetings & Events’ board.

    Ashfield Meetings &Events, healthcare event management specialist, is delighted to announce the key appointment of Laura Brown to the board of directors as Senior Vice President of Operations. ... The appointment of a second board director in the US is

  • Blue Latitude boosts its team

    Blue Latitude has appointed Ben Routley, Natalie Seebeck and Kasia Zygadlewicz to its team, following a series of new business wins and increased work from existing clients. ... Meanwhile, Elisa del Galdo has been appointed to Blue Latitude's board of

  • Eric Hansen appointed MD at PAN

    I am delighted to announce Eric’s appointment as Managing Director of PAN,’ says Catherine. ... Eric will lead the PAN Board of Directors comprising Arron O’Hare, Creative Director; Julia Straker, Director of Strategic Brand Planning and Sarah

  • PAN promotes Julia Straker to Director of Strategic Brand Planning

    Julia Straker who joined PAN in June 2012 has been promoted to Director of Strategic Brand Planning and joins the agency’s board of directors. ... Previously a planner at TBWA/Paling Walters, Straker has become an integral member of the PAN team with a

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics